Maze Therapeutics Inc. (MAZE)
NASDAQ: MAZE
· Real-Time Price · USD
11.30
0.04 (0.36%)
At close: Jun 20, 2025, 3:59 PM
11.18
-1.06%
After-hours: Jun 20, 2025, 04:20 PM EDT
0.36% (1D)
| Bid | 9.9 |
| Market Cap | 494.91M |
| Revenue (ttm) | 2.5M |
| Net Income (ttm) | -80.91M |
| EPS (ttm) | 0.07 |
| PE Ratio (ttm) | 161.43 |
| Forward PE | -3.28 |
| Analyst | Buy |
| Ask | 14.3 |
| Volume | 78,972 |
| Avg. Volume (20D) | 211,120 |
| Open | 11.40 |
| Previous Close | 11.26 |
| Day's Range | 10.70 - 11.64 |
| 52-Week Range | 6.71 - 17.00 |
| Beta | 1.85 |
About MAZE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MAZE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MAZE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
-10.08%
Maze Therapeutics shares are trading lower on poss...
Unlock content with
Pro Subscription
3 months ago
-2.31%
Maze Therapeutics shares are trading higher after JP Morgan initiated coverage on the stock with an Overweight rating and announced a price target of $30. Additionally, Leerink Partners initiated coverage on the stock with an Outperform rating and announced a price target of $28.
4 months ago · seekingalpha.com
U.S. IPO Weekly Recap: Active January Closes Out With Several Sizable IPOsFive IPOs listed this week, all of which raised over $100 million; one direct listing and three SPACs also debuted. Four microcaps submitted initial filings this week - Vistek, Awaysis Capital, QMSK T...